Retraining of the Amygdala and Insula for the Treatment of Persistent Covid
1 other identifier
interventional
120
1 country
1
Brief Summary
Prolonged COVID, also known as post-COVID or Sar-CoV-2 infection with post-acute sequelae, refers to a set of multi-organ symptoms that persist in patients who have suffered SARS-CoV-2 infection, even after of the acute phase of the disease. Approximately 10% of people experience this set of symptoms after their acute COVID has resolved. Such symptoms may include respiratory problems, myalgia, extreme fatigue, moodiness, cognitive impairment, and difficulty sleeping. Psychological therapies, such as mindfulness, have already demonstrated their effectiveness in pathologies of this type, improving mental health and physical function, as well as reinforcing acceptance and reducing symptoms. Specifically, amygdala-insula training was originally designed for patients with chronic fatigue syndrome as a method of reducing chronic over-sensitization and heightened fear response of the amygdala, which may be behind some of the symptoms related to both with this pathology as with fibromyalgia. A lot of research is currently being done on different types of treatments such as pharmaceutical, biological, dietary, homeopathic and rehabilitation for the treatment of persistent COVID; however, an effective treatment has not yet been found. Therefore, this study aims to evaluate the impact of a retraining intervention of the amygdala and insula for the improvement of the quality of life of patients with persistent COVID.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 20, 2023
CompletedFirst Posted
Study publicly available on registry
July 21, 2023
CompletedStudy Start
First participant enrolled
September 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2024
CompletedSeptember 16, 2025
September 1, 2025
7 months
July 20, 2023
September 10, 2025
Conditions
Outcome Measures
Primary Outcomes (6)
Short Form de 36 items (SF-36)
In the AIR + Mindfulness program group
Baseline
Short Form de 36 items (SF-36)
In the AIR + Mindfulness program group
Post-treatment 8 weeks from baseline
Short Form de 36 items (SF-36)
In the AIR + Mindfulness program group
Three-months follow-up
Short Form de 36 items (SF-36)
In the relaxation program group
Baseline
Short Form de 36 items (SF-36)
In the relaxation program group
Post-treatment 8 weeks from baseline
Short Form de 36 items (SF-36)
In the relaxation program group
Three-months follow-up
Secondary Outcomes (62)
Sociodemographic data Gender, age, marital status, education, occupation, economical level
Baseline
Sociodemographic data Gender, age, marital status, education, occupation, economical level
Baseline
Spanish Chronic Pain Grading Scale
Baseline
Spanish Chronic Pain Grading Scale
Baseline
Spanish Chronic Pain Grading Scale
Post-treatment 8 weeks from baseline
- +57 more secondary outcomes
Study Arms (2)
Amygdala & Insula Retraining + Mindfulness
EXPERIMENTALRelaxation condition
ACTIVE COMPARATORInterventions
AIR + Mindfulness program consists of 8 sessions of 120 minutes/session (10-12 people) Written material and sound recordings will be offered as support elements. The estimated duration of the program is two months.
Relaxation program consists of 8 sessions of 120 minutes/session (10-12 people) Written material and sound recordings will be offered as support elements. The estimated duration of the program is two months.
Eligibility Criteria
You may qualify if:
- Age: 18-30 years old.
- Grant informed consent.
- Diagnosis of persistent COVID by primary care physicians.
You may not qualify if:
- Age: \<18 years old
- Serious medical or psychiatric illnesses
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Psychiatry. Miguel Servet University Hospital
Zaragoza, 50009, Spain
Related Publications (1)
Gasion V, Barcelo-Soler A, Beltran-Ruiz M, Hijar-Aguinaga R, Camarero-Grados L, Lopez-Del-Hoyo Y, Garcia-Campayo J, Montero-Marin J. Effectiveness of an amygdala and insula retraining program combined with mindfulness training to improve the quality of life in patients with long COVID: a randomized controlled trial protocol. BMC Complement Med Ther. 2023 Nov 9;23(1):403. doi: 10.1186/s12906-023-04240-0.
PMID: 37946190DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
July 20, 2023
First Posted
July 21, 2023
Study Start
September 1, 2023
Primary Completion
March 31, 2024
Study Completion
March 31, 2024
Last Updated
September 16, 2025
Record last verified: 2025-09